{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:13:42Z","timestamp":1794669222754,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"8128","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.1038\/s41586-026-10838-4","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:20:13Z","timestamp":1782858013000},"page":"712-722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies"],"prefix":"10.1038","volume":"656","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-0229","authenticated-orcid":false,"given":"Lorie","family":"Marchitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshitij","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Roark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Coleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-3376","authenticated-orcid":false,"given":"Ashwin N.","family":"Skelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-0222","authenticated-orcid":false,"given":"Michael P.","family":"Hogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2812-8263","authenticated-orcid":false,"given":"Rumi","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasirajan","family":"Ayyanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3253-3309","authenticated-orcid":false,"given":"Zizhang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-660X","authenticated-orcid":false,"given":"Yicheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joena","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5069-504X","authenticated-orcid":false,"given":"Younghoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9393-3074","authenticated-orcid":false,"given":"Andrew J.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7518-6487","authenticated-orcid":false,"given":"Frederic","family":"Bibollet-Ruche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5721-0787","authenticated-orcid":false,"given":"Emily","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0970-3693","authenticated-orcid":false,"given":"Macy J.","family":"Akeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3534-7967","authenticated-orcid":false,"given":"Jinery","family":"Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Martella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-6824","authenticated-orcid":false,"given":"Yingying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda G.","family":"Lituchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3992-2936","authenticated-orcid":false,"given":"Rebecca A.","family":"Osbaldeston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette G.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie","family":"Albertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3441-7153","authenticated-orcid":false,"given":"Justin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6924-7415","authenticated-orcid":false,"given":"Chiaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4083-5251","authenticated-orcid":false,"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Amereh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuduo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes A.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-1405","authenticated-orcid":false,"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiees","family":"Andrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"Kreider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-6510","authenticated-orcid":false,"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-8819","authenticated-orcid":false,"given":"Lawrence","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3560-232X","authenticated-orcid":false,"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-5757","authenticated-orcid":false,"given":"Bette T.","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7643-9023","authenticated-orcid":false,"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7399-7954","authenticated-orcid":false,"given":"Kevin O.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-9887","authenticated-orcid":false,"given":"Beatrice H.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-4532","authenticated-orcid":false,"given":"George M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"10838_CR1","volume":"11","author":"R Habib","year":"2026","unstructured":"Habib, R. et al. Env-antibody coevolution identifies B cell priming as the principal bottleneck to HIV-1 V2 apex broadly neutralizing antibody development. Sci. Immunol. 11, eadz3933 (2026).","journal-title":"Sci. Immunol."},{"key":"10838_CR2","volume":"11","author":"AR Ghosh","year":"2026","unstructured":"Ghosh, A. R. et al. Acquisition of neutralization breadth following a single priming immunization in an HIV-1 V2 apex bnAb precursor mouse model. Sci. Immunol. 11, eadz5064 (2026).","journal-title":"Sci. Immunol."},{"key":"10838_CR3","doi-asserted-by":"publisher","first-page":"e1005369","DOI":"10.1371\/journal.ppat.1005369","volume":"12","author":"E Landais","year":"2016","unstructured":"Landais, E. et al. Broadly neutralizing antibody responses in a large longitudinal sub-saharan HIV primary infection cohort. PLoS Pathog. 12, e1005369 (2016).","journal-title":"PLoS Pathog."},{"key":"10838_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1570162X15666171124122044","volume":"16","author":"PL Moore","year":"2018","unstructured":"Moore, P. L. The neutralizing antibody response to the HIV-1 env protein. Curr. HIV Res. 16, 21\u201328 (2018).","journal-title":"Curr. HIV Res."},{"key":"10838_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/nm.4187","volume":"22","author":"P Rusert","year":"2016","unstructured":"Rusert, P. et al. Determinants of HIV-1 broadly neutralizing antibody induction. Nat. Med. 22, 1260\u20131267 (2016).","journal-title":"Nat. Med."},{"key":"10838_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41586-018-0517-0","volume":"561","author":"RD Kouyos","year":"2018","unstructured":"Kouyos, R. D. et al. Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature 561, 406\u2013410 (2018).","journal-title":"Nature"},{"key":"10838_CR7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20250638","volume":"222","author":"RS Roark","year":"2025","unstructured":"Roark, R. S. et al. Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies. J. Exp. Med. 222, e20250638 (2025).","journal-title":"J. Exp. Med."},{"key":"10838_CR8","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.immuni.2022.09.001","volume":"55","author":"JR Willis","year":"2022","unstructured":"Willis, J. R. et al. Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors. Immunity 55, 2149\u20132167 (2022).","journal-title":"Immunity"},{"key":"10838_CR9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2532810123","volume":"128","author":"R Habib","year":"2026","unstructured":"Habib, R. et al. Deep mining of the human antibody repertoire identifies frequent and immunogenetically diverse CDRH3 topologies targetable by vaccination. Proc. Natl Acad. Sci. USA 128, e2532810123 (2026).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10838_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-019-0879-y","volume":"566","author":"B Briney","year":"2019","unstructured":"Briney, B., Inderbitzin, A., Joyce, C. & Burton, D. R. Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature 566, 393\u2013397 (2019).","journal-title":"Nature"},{"key":"10838_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.immuni.2015.10.014","volume":"43","author":"R Andrabi","year":"2015","unstructured":"Andrabi, R. et al. Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design. Immunity 43, 959\u2013973 (2015).","journal-title":"Immunity"},{"key":"10838_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2017.09.024","volume":"21","author":"JE Voss","year":"2017","unstructured":"Voss, J. E. et al. Elicitation of neutralizing antibodies targeting the V2 apex of the HIV envelope trimer in a wild-type animal model. Cell Rep. 21, 222\u2013235 (2017).","journal-title":"Cell Rep."},{"key":"10838_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nsmb.3144","volume":"23","author":"J Gorman","year":"2016","unstructured":"Gorman, J. et al. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design. Nat. Struct. Mol. Biol. 23, 81\u201390 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10838_CR14","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.1128\/JVI.05045-11","volume":"85","author":"M Bonsignori","year":"2011","unstructured":"Bonsignori, M. et al. Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85, 9998\u201310009 (2011).","journal-title":"J. Virol."},{"key":"10838_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adt6660","volume":"10","author":"KM Ma","year":"2025","unstructured":"Ma, K. M. et al. HIV broadly neutralizing antibody precursors to the Apex epitope induced in nonhuman primates. Sci. Immunol. 10, eadt6660 (2025).","journal-title":"Sci. Immunol."},{"key":"10838_CR16","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.immuni.2026.03.012","volume":"59","author":"N Mishra","year":"2026","unstructured":"Mishra, N. et al. Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques. Immunity 59, 1140\u20131160 (2026).","journal-title":"Immunity"},{"key":"10838_CR17","doi-asserted-by":"publisher","unstructured":"Li, X. et al. Structure-guided design of native-like HIV env single chain trimers for enhanced stability, immunogenicity, and versatile vaccine delivery. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.10.25.684215 (2026).","DOI":"10.1101\/2025.10.25.684215"},{"key":"10838_CR18","doi-asserted-by":"publisher","unstructured":"Guenaga, J. et al. Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex. Nature https:\/\/doi.org\/10.1038\/s41586-026-10429-3 (2026).","DOI":"10.1038\/s41586-026-10429-3"},{"key":"10838_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay7199","volume":"366","author":"KO Saunders","year":"2019","unstructured":"Saunders, K. O. et al. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science 366, eaay7199 (2019).","journal-title":"Science"},{"key":"10838_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf0618","volume":"8","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages. Sci. Transl. Med. 8, 336ra362 (2016).","journal-title":"Sci. Transl. Med."},{"key":"10838_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.chom.2018.12.001","volume":"25","author":"CA Bricault","year":"2019","unstructured":"Bricault, C. A. et al. HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design. Cell Host Microbe 25, 59\u201372 (2019).","journal-title":"Cell Host Microbe"},{"key":"10838_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1126\/science.abd2638","volume":"371","author":"RS Roark","year":"2021","unstructured":"Roark, R. S. et al. Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth. Science 371, 142 (2021).","journal-title":"Science"},{"key":"10838_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13036","volume":"509","author":"NA Doria-Rose","year":"2014","unstructured":"Doria-Rose, N. A. et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature 509, 55\u201362 (2014).","journal-title":"Nature"},{"key":"10838_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"L Corey","year":"2021","unstructured":"Corey, L. et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N. Engl. J. Med. 384, 1003\u20131014 (2021).","journal-title":"N. Engl. J. Med."},{"key":"10838_CR25","doi-asserted-by":"publisher","first-page":"e1013739","DOI":"10.1371\/journal.ppat.1013739","volume":"22","author":"B Korber","year":"2026","unstructured":"Korber, B. et al. Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential. PLoS Pathog. 22, e1013739 (2026).","journal-title":"PLoS Pathog."},{"key":"10838_CR26","doi-asserted-by":"publisher","first-page":"W503","DOI":"10.1093\/nar\/gkn316","volume":"36","author":"X Brochet","year":"2008","unstructured":"Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, W503\u2013W508 (2008).","journal-title":"Nucleic Acids Res."},{"key":"10838_CR27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.immuni.2017.11.002","volume":"47","author":"E Landais","year":"2017","unstructured":"Landais, E. et al. HIV envelope glycoform heterogeneity and localized diversity govern the initiation and maturation of a V2 apex broadly neutralizing antibody lineage. Immunity 47, 990\u20131003 (2017).","journal-title":"Immunity"},{"key":"10838_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.immuni.2017.03.017","volume":"46","author":"JH Lee","year":"2017","unstructured":"Lee, J. H. et al. A broadly neutralizing antibody targets the dynamic HIV envelope trimer apex via a long, rigidified, and anionic \u03b2-hairpin structure. Immunity 46, 690\u2013702 (2017).","journal-title":"Immunity"},{"key":"10838_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39, 245\u2013258 (2013).","journal-title":"Immunity"},{"key":"10838_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.immuni.2012.08.012","volume":"37","author":"PD Kwong","year":"2012","unstructured":"Kwong, P. D. & Mascola, J. R. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37, 412\u2013425 (2012).","journal-title":"Immunity"},{"key":"10838_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.immuni.2017.08.006","volume":"47","author":"R Andrabi","year":"2017","unstructured":"Andrabi, R. et al. Glycans function as anchors for antibodies and help drive HIV broadly neutralizing antibody development. Immunity 47, 524\u2013537 (2017).","journal-title":"Immunity"},{"key":"10838_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature12053","volume":"496","author":"HX Liao","year":"2013","unstructured":"Liao, H. X. et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469\u2013476 (2013).","journal-title":"Nature"},{"key":"10838_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/nm.3963","volume":"21","author":"JN Bhiman","year":"2015","unstructured":"Bhiman, J. N. et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat. Med. 21, 1332\u20131336 (2015).","journal-title":"Nat. Med."},{"key":"10838_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2016.02.022","volume":"165","author":"M Bonsignori","year":"2016","unstructured":"Bonsignori, M. et al. Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody. Cell 165, 449\u2013463 (2016).","journal-title":"Cell"},{"key":"10838_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7514","volume":"9","author":"M Bonsignori","year":"2017","unstructured":"Bonsignori, M. et al. Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Sci. Transl. Med. 9, eaai7514 (2017).","journal-title":"Sci. Transl. Med."},{"key":"10838_CR36","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.3390\/v7102881","volume":"7","author":"P Hraber","year":"2015","unstructured":"Hraber, P. et al. Longitudinal antigenic sequences and sites from intra-host evolution (LASSIE) identifies immune-selected HIV variants. Viruses 7, 5443\u20135475 (2015).","journal-title":"Viruses"},{"key":"10838_CR37","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh, M. G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877\u20132892 (2021).","journal-title":"Immunity"},{"key":"10838_CR38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20171450","volume":"215","author":"N Pardi","year":"2018","unstructured":"Pardi, N. et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J. Exp. Med. 215, 1571\u20131588 (2018).","journal-title":"J. Exp. Med."},{"key":"10838_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26579-z","volume":"12","author":"M Lee","year":"2021","unstructured":"Lee, M. et al. Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces. Nat. Commun. 12, 6470 (2021).","journal-title":"Nat. Commun."},{"key":"10838_CR40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0022-1759(96)00126-3","volume":"197","author":"X L\u00fc","year":"1996","unstructured":"L\u00fc, X. & Miller, C. J. Concentration of IgG in the sera of normal rhesus macaques as determined by a species-specific radial immunodiffusion assay. J. Immunol. Methods 197, 193\u2013196 (1996).","journal-title":"J. Immunol. Methods"},{"key":"10838_CR41","doi-asserted-by":"publisher","unstructured":"Coleon, S. et al. Rapid vaccine induction of macaque HIV-1 V2 apex broadly neutralizing antibodies with immunogenetic signatures that are potentially translatable to humans. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.05.27.728024 (2026).","DOI":"10.64898\/2026.05.27.728024"},{"key":"10838_CR42","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s41591-022-01953-6","volume":"28","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition. Nat. Med. 28, 1924\u20131932 (2022).","journal-title":"Nat. Med."},{"key":"10838_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo5598","volume":"14","author":"KO Saunders","year":"2022","unstructured":"Saunders, K. O. et al. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection. Sci. Transl. Med. 14, eabo5598 (2022).","journal-title":"Sci. Transl. Med."},{"key":"10838_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2018.11.011","volume":"50","author":"MG Pauthner","year":"2019","unstructured":"Pauthner, M. G. et al. Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers. Immunity 50, 241\u2013252 (2019).","journal-title":"Immunity"},{"key":"10838_CR45","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.20112655","volume":"209","author":"LE McCoy","year":"2012","unstructured":"McCoy, L. E. et al. Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization. J. Exp. Med. 209, 1091\u20131103 (2012).","journal-title":"J. Exp. Med."},{"key":"10838_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature23301","volume":"548","author":"D Sok","year":"2017","unstructured":"Sok, D. et al. Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature 548, 108\u2013111 (2017).","journal-title":"Nature"},{"key":"10838_CR47","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1016\/j.cell.2024.10.003","volume":"187","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques. Cell 187, 7214\u20137231 (2024).","journal-title":"Cell"},{"key":"10838_CR48","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1016\/j.cell.2024.04.033","volume":"187","author":"WB Williams","year":"2024","unstructured":"Williams, W. B. et al. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans. Cell 187, 2919\u20132934 (2024).","journal-title":"Cell"},{"key":"10838_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2023.12.002","volume":"187","author":"KO Saunders","year":"2024","unstructured":"Saunders, K. O. et al. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques. Cell 187, 79\u201394 (2024).","journal-title":"Cell"},{"key":"10838_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","volume":"45","author":"JM Steichen","year":"2016","unstructured":"Steichen, J. M. et al. HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity 45, 483\u2013496 (2016).","journal-title":"Immunity"},{"key":"10838_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax4380","volume":"366","author":"JM Steichen","year":"2019","unstructured":"Steichen, J. M. et al. A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses. Science 366, eaax4380 (2019).","journal-title":"Science"},{"key":"10838_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady6831","volume":"17","author":"KR Parks","year":"2025","unstructured":"Parks, K. R. et al. Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial. Sci. Transl. Med. 17, eady6831 (2025).","journal-title":"Sci. Transl. Med."},{"key":"10838_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine, J. et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711\u2013716 (2013).","journal-title":"Science"},{"key":"10838_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.aac5894","volume":"349","author":"JG Jardine","year":"2015","unstructured":"Jardine, J. G. et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349, 156\u2013161 (2015).","journal-title":"Science"},{"key":"10838_CR55","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","volume":"351","author":"JG Jardine","year":"2016","unstructured":"Jardine, J. G. et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science 351, 1458\u20131463 (2016).","journal-title":"Science"},{"key":"10838_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk1533","volume":"13","author":"A Escolano","year":"2021","unstructured":"Escolano, A. et al. Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Sci. Transl. Med. 13, eabk1533 (2021).","journal-title":"Sci. Transl. Med."},{"key":"10838_CR57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-025-02408-z","volume":"27","author":"I Relano-Rodriguez","year":"2025","unstructured":"Relano-Rodriguez, I. et al. Rapid elicitation of a new class of neutralizing N332-glycan independent V3-glycan antibodies against HIV-1 in nonhuman primates. Nat. Immunol. 27, 586\u2013599 (2025).","journal-title":"Nat. Immunol."},{"key":"10838_CR58","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.celrep.2017.12.028","volume":"21","author":"KO Saunders","year":"2017","unstructured":"Saunders, K. O. et al. Vaccine induction of heterologous tier 2 HIV-1 neutralizing antibodies in animal models. Cell Rep. 21, 3681\u20133690 (2017).","journal-title":"Cell Rep."},{"key":"10838_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00071-21","volume":"95","author":"H Li","year":"2021","unstructured":"Li, H. et al. New SHIVs and improved design strategy for modeling HIV-1 transmission, immunopathogenesis, prevention and cure. J. Virol. 95, e00071-21 (2021).","journal-title":"J. Virol."},{"key":"10838_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/science.aec6396","author":"AN Skelly","year":"2026","unstructured":"Skelly, A. N. et al. A novel two-step mechanism for inducing broadly neutralizing HIV antibodies in rhesus macaques. Science https:\/\/doi.org\/10.1126\/science.aec6396 (2026).","journal-title":"Science"},{"key":"10838_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312 (2003).","journal-title":"Nature"},{"key":"10838_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jim.2013.11.022","volume":"409","author":"M Sarzotti-Kelsoe","year":"2014","unstructured":"Sarzotti-Kelsoe, M. et al. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1. J. Immunol. Methods 409, 131\u2013146 (2014).","journal-title":"J. Immunol. Methods"},{"key":"10838_CR63","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.celrep.2019.12.091","volume":"30","author":"Q Han","year":"2020","unstructured":"Han, Q. et al. Neonatal rhesus macaques have distinct immune cell transcriptional profiles following HIV envelope immunization. Cell Rep. 30, 1553\u20131569 (2020).","journal-title":"Cell Rep."},{"key":"10838_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"10838_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41592-019-0433-8","volume":"16","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. Nat. Methods 16, 619\u2013626 (2019).","journal-title":"Nat. Methods"},{"key":"10838_CR66","doi-asserted-by":"crossref","unstructured":"Lees, W. D. et al. The current landscape of adaptive immune receptor genomic and repertoire data: OGRDB and VDJbase. Nucleic Acids Res 54, D932\u2013D937 (2025).","DOI":"10.1093\/nar\/gkaf1094"},{"key":"10838_CR67","doi-asserted-by":"publisher","first-page":"e1005537","DOI":"10.1371\/journal.ppat.1005537","volume":"12","author":"RD Mason","year":"2016","unstructured":"Mason, R. D. et al. Targeted isolation of antibodies directed against major sites of SIV Env vulnerability. PLoS Pathog. 12, e1005537 (2016).","journal-title":"PLoS Pathog."},{"key":"10838_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41596-018-0084-8","volume":"14","author":"RF Thompson","year":"2019","unstructured":"Thompson, R. F., Iadanza, M. G., Hesketh, E. L., Rawson, S. & Ranson, N. A. Collection, pre-processing and on-the-fly analysis of data for high-resolution, single-particle cryo-electron microscopy. Nat. Protoc. 14, 100\u2013118 (2019).","journal-title":"Nat. Protoc."},{"key":"10838_CR69","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10838_CR70","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"10838_CR71","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. D"},{"key":"10838_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1107\/S0909049503024130","volume":"11","author":"PD Adams","year":"2004","unstructured":"Adams, P. D. et al. Recent developments in the PHENIX software for automated crystallographic structure determination. J. Synchrotron Radiat. 11, 53\u201355 (2004).","journal-title":"J. Synchrotron Radiat."},{"key":"10838_CR73","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"10838_CR74","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"10838_CR75","doi-asserted-by":"publisher","first-page":"W615","DOI":"10.1093\/nar\/gkh398","volume":"32","author":"IW Davis","year":"2004","unstructured":"Davis, I. W., Murray, L. W., Richardson, J. S. & Richardson, D. C. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Res. 32, W615\u2013W619 (2004).","journal-title":"Nucleic Acids Res."},{"key":"10838_CR76","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"10838_CR77","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1093\/bioinformatics\/btz921","volume":"36","author":"A Tareen","year":"2020","unstructured":"Tareen, A. & Kinney, J. B. Logomaker: beautiful sequence logos in Python. Bioinformatics 36, 2272\u20132274 (2020).","journal-title":"Bioinformatics"},{"key":"10838_CR78","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"10838_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10899-2","volume":"10","author":"Q Han","year":"2019","unstructured":"Han, Q. et al. Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations. Nat. Commun. 10, 2898 (2019).","journal-title":"Nat. Commun."},{"key":"10838_CR80","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/j.celrep.2019.04.082","volume":"27","author":"R Andrabi","year":"2019","unstructured":"Andrabi, R. et al. The chimpanzee SIV envelope trimer: Structure and deployment as an HIV vaccine template. Cell Rep. 27, 2426\u20132441 (2019).","journal-title":"Cell Rep."},{"key":"10838_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110514","volume":"38","author":"Z Mu","year":"2022","unstructured":"Mu, Z. et al. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice. Cell Rep. 38, 110514 (2022).","journal-title":"Cell Rep."},{"key":"10838_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersdorfer","year":"2019","unstructured":"Baiersdorfer, M. et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26\u201335 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10838_CR83","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Kariko","year":"2005","unstructured":"Kariko, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"10838_CR84","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. Engl. 51, 8529\u20138533 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10838_CR85","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"10838_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf1152","volume":"6","author":"M Silva","year":"2021","unstructured":"Silva, M. et al. A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity. Sci. Immunol. 6, eabf1152 (2021).","journal-title":"Sci. Immunol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10838-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:02:05Z","timestamp":1787209325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10838-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":86,"journal-issue":{"issue":"8128","published-print":{"date-parts":[[2026,8,20]]}},"alternative-id":["10838"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10838-4","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.M., K.W., B.T.K., G.M.S., B.H.H., W.D., K.O.S., E.F.K., D.W. and B.F.H. have patents submitted on the vaccine designs in this paper. D.J.I. is listed as an inventor on a patent related to SMNP adjuvant (US11,547,672). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}